Corporate News     09-Nov-22
Natco Pharma launches first generic version of Pomalyst® capsules
Natco Pharma announced the launch of first generic version of Pomalyst® (Pomalidomide) Capsules in 1,2,3,4 mg strengths in the Australian market. The product was launched by NATCO's commercial partner Juno Pharmaceuticals.

Pomalidomide is prescribed for treatment of Multiple Myeloma and Kaposi Sarcoma.

Pomalyst® registered sales of USD 35.6 million in the Australian market for the year ending 31 March 2022 as per industry sales data.

Previous News
  Barometers trade with modest losses; European mkt slides
 ( Market Commentary - Mid-Session 04-Sep-24   13:33 )
  Sensex, Nifty end lower amid global cues; PSU bank shares slides; VIX rallies 3.86%
 ( Market Commentary - Quick Review 04-Sep-24   15:51 )
  Natco Pharma
 ( Results - Analysis 15-Feb-24   10:36 )
  Natco Pharma consolidated net profit rises 59.05% in the June 2024 quarter
 ( Results - Announcements 12-Aug-24   15:07 )
  Natco Pharma Ltd leads gainers in 'A' group
 ( Hot Pursuit - 16-Feb-24   12:00 )
  Natco Pharma Ltd spurts 4.93%, up for third straight session
 ( Hot Pursuit - 07-Jun-24   13:05 )
  Board of Natco Pharma recommends Second Interim Dividend
 ( Corporate News - 16-Nov-23   09:39 )
  Natco Pharma temporarily shuts operations at Chennai-based plant
 ( Hot Pursuit - 07-Dec-23   15:14 )
  Natco Pharma update on litigation regarding Pomalidomide capsules
 ( Corporate News - 21-Dec-23   12:56 )
  Natco Pharma gains as board OKs Rs 210-cr share buyback
 ( Hot Pursuit - 08-Mar-23   12:09 )
  Natco Pharma Ltd up for third straight session
 ( Hot Pursuit - 25-Jan-24   13:06 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top